The Transcriptional Coregulator RIP140 Represses E2F1 Activity and Discriminates Breast Cancer Subtypes

Aurélie Docquier, Pierre-Olivier Harmand, Samuel Fritsch, +3

Clinical Cancer Research

The nuclear receptor transcriptional coregulator RIP140

Patrick Augereau, Éric Badia, Sophie Carascossa, +5

Nuclear Receptor Signaling

GeneticsEpigeneticsTranscriptional RegulationCell SignalingRip140 Gene +16

Cognitive impairments in adult mice with constitutive inactivation of <i>RIP140</i> gene expression

Florian Duclot, Marion Lapierre, Samuel Fritsch, +4

Genes Brain & Behavior

Intravenous Delivery of PTH/PTHrP Type 1 Receptor cDNA to Rats Decreases Heart Rate, Blood Pressure, Renal Tone, Renin Angiotensin System, and Stress-Induced Cardiovascular Responses

Samuel Fritsch, Véronique Lindner, Sandra Welsch, +5

Journal of the American Society of Nephrology

The E3 Ubiquitin Ligase Thyroid Hormone Receptor-interacting Protein 12 Targets Pancreas Transcription Factor 1a for Proteasomal Degradation

Naı̈ma Hanoun, Samuel Fritsch, Odile Gayet, +5

Journal of Biological Chemistry

Transcript Expression of the Tuberoinfundibular Peptide (TIP)39/PTH2 Receptor System and Non-PTH1 Receptor-Mediated Tonic Effects of TIP39 and Other PTH2 Receptor Ligands in Renal Vessels

Anne Eichinger, Nathalie Fiaschi‐Taesch, Thierry Massfelder, +3

Endocrinology

RIP140 inhibits glycolysis-dependent proliferation of breast cancer cells by regulating GLUT3 expression through transcriptional crosstalk between hypoxia induced factor and p53

Valentin Jacquier, Delphine Gitenay, Samuel Fritsch, +6

Cellular and Molecular Life Sciences

Type 1 Parathyroid Hormone Receptor Expression Level Modulates Renal Tone and Plasma Renin Activity in Spontaneously Hypertensive Rat

Thierry Massfelder, Nathalie Taesch, Samuel Fritsch, +4

Journal of the American Society of Nephrology

HypertensionRenal InflammationParathyroid DiseaseParathyroid GlandMolecular Pharmacology +20

Comparison of different regimens of estradiol benzoate treatments followed by long-acting progesterone to prepare noncycling mares as embryo recipients

Elisa S.M. Silva, J.F. Roser, Anny Raissa Carolini Gomes, +4

Theriogenology

Animal ReproductionTheriogenologyFertilityMedicineGynecology +7

Administration of 2.5 mg of estradiol followed by 1,500 mg of progesterone to anovulatory mares promote similar uterine morphology, hormone concentrations and molecular dynamics to those observed in cyclic mares

Elisa S.M. Silva, Fernanda Saules Ignácio, Samuel Fritsch, +4

Theriogenology

Animal PhysiologySimilar Uterine MorphologyTheriogenologyFertilityCyclic Mares +8